Literature DB >> 7318492

Aqueous humour and plasma cortisol levels in glaucoma and cataract patients.

P Rozsíval, R Hampl, J Obenberger, L Stárka, S Rehák.   

Abstract

By means of radioimmunoassay, the content of endogenous cortisol in the aqueous humour and plasma of 35 patients suffering from various types of glaucomas and 35 cataract patients was determined, and the ratio of the plasma to the aqueous humour cortisol levels was calculated. The highest cortisol level in both plasma and aqueous humour was found to occur in patients with open-angle glaucoma suffering at the same time from systemic hypertension. The lowest plasma to aqueous humour cortisol ratio was found in patients with secondary glaucoma treated with steroids. In woman suffering from open-angle glaucoma, the rising cortisol level in plasma with age contrasted to the decreasing cortisol level in aqueous humour. The authors suggest that there is an active interference with homeostatic mechanisms responsible for ensuring the stability of the eye inner milieu and a certain protection of the trabecular meshwork of the angle of the anterior eye chamber against noxious effects of the endogenous cortisol.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7318492     DOI: 10.3109/02713688109019976

Source DB:  PubMed          Journal:  Curr Eye Res        ISSN: 0271-3683            Impact factor:   2.424


  10 in total

Review 1.  Role of the alternatively spliced glucocorticoid receptor isoform GRβ in steroid responsiveness and glaucoma.

Authors:  Ankur Jain; Robert J Wordinger; Thomas Yorio; Abbot F Clark
Journal:  J Ocul Pharmacol Ther       Date:  2014-02-07       Impact factor: 2.671

2.  Spliceosome protein (SRp) regulation of glucocorticoid receptor isoforms and glucocorticoid response in human trabecular meshwork cells.

Authors:  Ankur Jain; Robert J Wordinger; Thomas Yorio; Abbot F Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-02-21       Impact factor: 4.799

3.  Assessment of SNPs associated with the human glucocorticoid receptor in primary open-angle glaucoma and steroid responders.

Authors:  John H Fingert; Wallace L Alward; Kai Wang; Thomas Yorio; Abbot F Clark
Journal:  Mol Vis       Date:  2010-04-03       Impact factor: 2.367

Review 4.  Glucocorticoid therapy and ocular hypertension.

Authors:  Adnan Dibas; Thomas Yorio
Journal:  Eur J Pharmacol       Date:  2016-07-05       Impact factor: 4.432

5.  Genome-wide association study of intraocular pressure identifies the GLCCI1/ICA1 region as a glaucoma susceptibility locus.

Authors: 
Journal:  Hum Mol Genet       Date:  2013-07-07       Impact factor: 6.150

Review 6.  Current intravitreal therapy and ocular hypertension: A review.

Authors:  Aditya Sudhalkar; Alper Bilgic; Shail Vasavada; Laurent Kodjikian; Thibaud Mathis; Fransesc March de Ribot; Thanos Papakostas; Viraj Vasavada; Vaishali Vasavada; Samaresh Srivastava; Deepak Bhojwani; Pooja Ghia; Anand Sudhalkar
Journal:  Indian J Ophthalmol       Date:  2021-02       Impact factor: 1.848

7.  Mimicking chronic glaucoma over 6 months with a single intracameral injection of dexamethasone/fibronectin-loaded PLGA microspheres.

Authors:  Alba Aragón-Navas; María J Rodrigo; David Garcia-Herranz; Teresa Martinez; Manuel Subias; Silvia Mendez; Jesús Ruberte; Judit Pampalona; Irene Bravo-Osuna; Julian Garcia-Feijoo; Luis E Pablo; Elena Garcia-Martin; Rocío Herrero-Vanrell
Journal:  Drug Deliv       Date:  2022-12       Impact factor: 6.819

8.  Characterization of rabbit myocilin: Implications for human myocilin glycosylation and signal peptide usage.

Authors:  Allan R Shepard; Nasreen Jacobson; Ruifang Sui; H Thomas Steely; Andrew J Lotery; Edwin M Stone; Abbot F Clark
Journal:  BMC Genet       Date:  2003-04-02       Impact factor: 2.797

9.  Glucocorticoid Receptor Transactivation Is Required for Glucocorticoid-Induced Ocular Hypertension and Glaucoma.

Authors:  Gaurang C Patel; J Cameron Millar; Abbot F Clark
Journal:  Invest Ophthalmol Vis Sci       Date:  2019-05-01       Impact factor: 4.799

10.  Dexamethasone and Glucocorticoid-Induced Matrix Temporally Modulate Key Integrins, Caveolins, Contractility, and Stiffness in Human Trabecular Meshwork Cells.

Authors:  Felix Yemanyi; Hasna Baidouri; Alan R Burns; VijayKrishna Raghunathan
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-11-02       Impact factor: 4.799

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.